Literature DB >> 17374867

Patterns of contrast enhancement in the brain and meninges.

James G Smirniotopoulos1, Frances M Murphy, Elizabeth J Rushing, John H Rees, Jason W Schroeder.   

Abstract

Contrast material enhancement for cross-sectional imaging has been used since the mid 1970s for computed tomography and the mid 1980s for magnetic resonance imaging. Knowledge of the patterns and mechanisms of contrast enhancement facilitate radiologic differential diagnosis. Brain and spinal cord enhancement is related to both intravascular and extravascular contrast material. Extraaxial enhancing lesions include primary neoplasms (meningioma), granulomatous disease (sarcoid), and metastases (which often manifest as mass lesions). Linear pachymeningeal (dura-arachnoid) enhancement occurs after surgery and with spontaneous intracranial hypotension. Leptomeningeal (pia-arachnoid) enhancement is present in meningitis and meningoencephalitis. Superficial gyral enhancement is seen after reperfusion in cerebral ischemia, during the healing phase of cerebral infarction, and with encephalitis. Nodular subcortical lesions are typical for hematogenous dissemination and may be neoplastic (metastases) or infectious (septic emboli). Deeper lesions may form rings or affect the ventricular margins. Ring enhancement that is smooth and thin is typical of an organizing abscess, whereas thick irregular rings suggest a necrotic neoplasm. Some low-grade neoplasms are "fluid-secreting," and they may form heterogeneously enhancing lesions with an incomplete ring sign as well as the classic "cyst-with-nodule" morphology. Demyelinating lesions, including both classic multiple sclerosis and tumefactive demyelination, may also create an open ring or incomplete ring sign. Thick and irregular periventricular enhancement is typical for primary central nervous system lymphoma. Thin enhancement of the ventricular margin occurs with infectious ependymitis. Understanding the classic patterns of lesion enhancement--and the radiologic-pathologic mechanisms that produce them--can improve image assessment and differential diagnosis.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17374867     DOI: 10.1148/rg.272065155

Source DB:  PubMed          Journal:  Radiographics        ISSN: 0271-5333            Impact factor:   5.333


  104 in total

1.  MR imaging in hepatocellular carcinoma: correlations between MRI features and molecular marker VEGF.

Authors:  Zhaoqin Huang; Xiangjiao Meng; Jianjun Xiu; Xiuqin Xu; Lei Bi; Jie Zhang; Xue Han; Qingwei Liu
Journal:  Med Oncol       Date:  2014-11-04       Impact factor: 3.064

2.  Spiral head CT in the evaluation of acute intracranial pathology: a pictorial essay.

Authors:  Aaron Sodickson; Heitor Okanobo; Stephen Ledbetter
Journal:  Emerg Radiol       Date:  2010-10-13

Review 3.  Pachymeningeal enhancement-a comprehensive review of literature.

Authors:  Joyce Antony; Craig Hacking; Rosalind L Jeffree
Journal:  Neurosurg Rev       Date:  2015-08-13       Impact factor: 3.042

4.  Prognostic Value of Preoperative MRI Metrics for Diffuse Lower-Grade Glioma Molecular Subtypes.

Authors:  P Darvishi; P P Batchala; J T Patrie; L M Poisson; M-B Lopes; R Jain; C E Fadul; D Schiff; S H Patel
Journal:  AJNR Am J Neuroradiol       Date:  2020-04-23       Impact factor: 3.825

5.  Mass spectrometry imaging as a tool for surgical decision-making.

Authors:  David Calligaris; Isaiah Norton; Daniel R Feldman; Jennifer L Ide; Ian F Dunn; Livia S Eberlin; R Graham Cooks; Ferenc A Jolesz; Alexandra J Golby; Sandro Santagata; Nathalie Y Agar
Journal:  J Mass Spectrom       Date:  2013-11       Impact factor: 1.982

Review 6.  Brain metastases: neuroimaging.

Authors:  Whitney B Pope
Journal:  Handb Clin Neurol       Date:  2018

Review 7.  Errors in neuroradiology.

Authors:  Ferdinando Caranci; Enrico Tedeschi; Giuseppe Leone; Alfonso Reginelli; Gianluca Gatta; Antonio Pinto; Ettore Squillaci; Francesco Briganti; Luca Brunese
Journal:  Radiol Med       Date:  2015-07-17       Impact factor: 3.469

Review 8.  Chimeric Antigen Receptor T-Cell Therapy: What the Neuroradiologist Needs to Know.

Authors:  H A Valand; F Huda; R K Tu
Journal:  AJNR Am J Neuroradiol       Date:  2019-05-02       Impact factor: 3.825

9.  Common infectious diseases of the central nervous system-clinical features and imaging characteristics.

Authors:  Shan Li; Ivy P Nguyen; Kyle Urbanczyk
Journal:  Quant Imaging Med Surg       Date:  2020-12

10.  A small noncoding RNA signature found in exosomes of GBM patient serum as a diagnostic tool.

Authors:  Lorea Manterola; Elizabeth Guruceaga; Jaime Gállego Pérez-Larraya; Marisol González-Huarriz; Patricia Jauregui; Sonia Tejada; Ricardo Diez-Valle; Victor Segura; Nicolás Samprón; Cristina Barrena; Irune Ruiz; Amaia Agirre; Angel Ayuso; Javier Rodríguez; Alvaro González; Enric Xipell; Ander Matheu; Adolfo López de Munain; Teresa Tuñón; Idoya Zazpe; Jesús García-Foncillas; Sophie Paris; Jean Yves Delattre; Marta M Alonso
Journal:  Neuro Oncol       Date:  2014-01-16       Impact factor: 12.300

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.